News & Insights

Insights
23rd June 2022

BIO International in San Diego: Sunny with scattered economic clouds

The biopharma universe gathered in San Diego last week for the first face to face BIO International conference in three years. Turn-out was good but below the get-together in Philadelphia in 2019. That one topped out above 17,000 attendees according to the BIO website; whisper numbers this time around were in the region of 12,000. I […]

Events
17th June 2022

Partnering with Private Equity: the Inside Story

Date:
05/07/2022
Venue:
Home House, 20 Portman Square, London W1H 6LW
Time:
8:15 - 10:00
Insights
25th May 2022

Biotech funding in a risk-off climate – does upstream trouble loom for pharma services providers?

Biotech funding is the key driver of innovation in the pharmaceutical industry and is essential in supporting the healthcare ecosystem. More than 80% of drugs marketed by large pharmaceutical companies were discovered and initially developed by biotechs1. Biotech companies also discovered more than 60% of FDA-approved “priority” drugs, which treat life-threatening conditions and offer significant […]

Insights
24th May 2022

Crossrail opens – a big day for travellers to and workers in London

At Results Healthcare we execute transactions around the world, with active projects in North America, Europe and Asia Pacific, so we see ourselves as a global organisation with offices and employees in London and New York, so a blog on transport in London might seem oddly parochial, but the opening of Crossrail, or the Elizabeth […]

Events
23rd May 2022

BIO International Convention June 13-16, 2022 – San Diego, CA

Date:
13/06/2022
Venue:
San Diego, CA, USA
Reports
4th May 2022

The Technology Services Perspective – Q1 2022

Deal activity for Q1 2022 has increased 30% over the previous quarter, to a total of 237 transactions. Transactions have mainly focused on strategic tuck-ins that are centred around acquiring next-gen and nearshore capabilities, such as robotic process automation, customer experience consultancy and influencer-based social media marketing. Even in the current macro environment, March showed […]

Reports
4th May 2022

The CyberScope – Q1 2022

Despite a backdrop of some macroeconomic uncertainty, the first quarter of 2022 started strong with 52 M&A transactions, representing a 41% increase from Q1 last year, as the security sector again proves its strong resilience. Google’s $5.4Bn acquisition of cloud and managed cybersecurity provider, Mandiant, very clearly demonstrated the opening of a new front in […]

Reports
4th May 2022

The Enterprise Stack – Q1 2022

The private M&A market witnessed a record quarter for deal volumes in Q1 2022, reaching just shy of 600 deals. This was delivered on the back of continued adoption of cloud technologies, increased investment into hybrid work environments and software vendors seeking to deepen their security posture. Results advised AI-powered brand language optimisation platform Phrasee […]

Insights
6th April 2022

Partnering with Private Equity: Insights and perspectives from Tony Hill  at Sideshow and Dominic Graham at Waterland Private Equity

In February of 2021, Sideshow, an independent digital group, partnered with Waterland Private Equity to support its ambitious growth plans to continue building a group of highly connected digital brands. One year on we caught up with Sideshow’s Tony Hill, Founder and CEO, and Dominic Graham, Investment Director at Waterland to discuss the journey to […]

Subscribe

We add value by understanding our sectors inside-out, and we release regular industry research and reports on key trends in the technology and healthcare sectors. Fill out the form to start receiving alerts when we publish new content or to follow our latest deals, upcoming events and company updates.

  • This field is for validation purposes and should be left unchanged.